Welcome to LookChem.com Sign In|Join Free

CAS

  • or
BOC-6-AMINOHEXANOIC ACID is an alkane chain with terminal carboxylic acid and Boc-protected amino groups. It is a versatile compound used in various applications, including the synthesis of proteolysis-targeting chimeras (PROTACs) and other conjugation applications. The terminal carboxylic acid can react with primary amine groups to form a stable amide bond, while the Boc group can be deprotected under mild acidic conditions to form the free amine.

6404-29-1 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 6404-29-1 Structure
  • Basic information

    1. Product Name: BOC-6-AMINOHEXANOIC ACID
    2. Synonyms: Boc-6-Ahx-OH ,98.5%(HPLC);Boc-6-Ahx-OH,6-(Boc-amino)caproic acid, 6-(Boc-amino)hexanoic acid, Boc-6-aminohexanoic acid;Boc-6-Ahx-OH(Boc-6-aMinohexanoic acid);Boc-ε- AMinocaproic acid Boc-ε- AMinocaproic acid;6-[N-(tert-Butoxycarbonyl)aMino]caproic Acid;N-(tert-Butoxycarbonyl)-ε-aMinocaproic Acid;N-(tert-Butoxycarbonyl)-ε-aMinohexanoic Acid;N-(tert-Butyloxycarbonyl)-ε-aMinocaproic Acid
    3. CAS NO:6404-29-1
    4. Molecular Formula: C11H21NO4
    5. Molecular Weight: 231.29
    6. EINECS: N/A
    7. Product Categories: Aliphatics;Amines;Amino Acids;Unusual Amino Acids;Amino Acid Derivatives
    8. Mol File: 6404-29-1.mol
  • Chemical Properties

    1. Melting Point: 35-40 °C
    2. Boiling Point: 166°C/0.3mmHg(lit.)
    3. Flash Point: 183.8oC
    4. Appearance: White/Powder
    5. Density: 1.065g/cm3
    6. Vapor Pressure: 7.76E-07mmHg at 25°C
    7. Refractive Index: 1.464
    8. Storage Temp.: 2-8°C
    9. Solubility: Chloroform, Ethyl Acetate
    10. PKA: 4.76±0.10(Predicted)
    11. Water Solubility: Soluble in chloroform and ethyl acetate. Slightly soluble in water.
    12. BRN: 2049561
    13. CAS DataBase Reference: BOC-6-AMINOHEXANOIC ACID(CAS DataBase Reference)
    14. NIST Chemistry Reference: BOC-6-AMINOHEXANOIC ACID(6404-29-1)
    15. EPA Substance Registry System: BOC-6-AMINOHEXANOIC ACID(6404-29-1)
  • Safety Data

    1. Hazard Codes: Xi
    2. Statements: 36/37/38
    3. Safety Statements: 22-24/25-26
    4. WGK Germany: 3
    5. RTECS:
    6. F: 21
    7. HazardClass: IRRITANT
    8. PackingGroup: N/A
    9. Hazardous Substances Data: 6404-29-1(Hazardous Substances Data)

6404-29-1 Usage

Uses

Used in Pharmaceutical Industry:
BOC-6-AMINOHEXANOIC ACID is used as a building block for the synthesis of esters of 6-aminohexanoic acid, which serve as antibacterial agents. EACA, an ester of 6-aminohexanoic acid, is known to inhibit chymotrypsin, Factor VIIa, lysine carboxy peptidase, plasmin, and plasminogen activator.
Used in Chemical Synthesis:
BOC-6-AMINOHEXANOIC ACID is used as a PROTAC linker in the synthesis of proteolysis-targeting chimeras (PROTACs). These chimeras are designed to modulate protein degradation and have potential applications in the development of targeted therapies for various diseases.
Used in Research and Development:
BOC-6-AMINOHEXANOIC ACID is used in the preparation of esters of 6-aminohexanoic acid for research purposes. These esters can be further modified and studied for their potential applications in various fields, such as drug development and material science.

Check Digit Verification of cas no

The CAS Registry Mumber 6404-29-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,4,0 and 4 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 6404-29:
(6*6)+(5*4)+(4*0)+(3*4)+(2*2)+(1*9)=81
81 % 10 = 1
So 6404-29-1 is a valid CAS Registry Number.
InChI:InChI=1/C11H21NO4/c1-11(2,3)16-10(15)12-8-6-4-5-7-9(13)14/h4-8H2,1-3H3,(H,12,15)(H,13,14)

6404-29-1 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (H61350)  6-(Boc-amino)hexanoic acid, 95%   

  • 6404-29-1

  • 5g

  • 643.0CNY

  • Detail
  • Alfa Aesar

  • (H61350)  6-(Boc-amino)hexanoic acid, 95%   

  • 6404-29-1

  • 25g

  • 2572.0CNY

  • Detail
  • Aldrich

  • (15395)  Boc-6-Ahx-OH  ≥99.0% (T)

  • 6404-29-1

  • 15395-1G

  • 293.67CNY

  • Detail
  • Aldrich

  • (15395)  Boc-6-Ahx-OH  ≥99.0% (T)

  • 6404-29-1

  • 15395-5G

  • 1,044.81CNY

  • Detail

6404-29-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name Boc-6-aminohexanoic acid

1.2 Other means of identification

Product number -
Other names 6-[(2-methylpropan-2-yl)oxycarbonylamino]hexanoic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:6404-29-1 SDS

6404-29-1Relevant articles and documents

Preparation, physicochemical properties, and transfection activities of tartaric acid-based cationic lipids as effective nonviral gene delivery vectors

Wan, Ning,Jia, Yi-Yang,Hou, Yi-Lin,Ma, Xi-Xi,He, Yong-Sheng,Li, Chen,Zhou, Si-Yuan,Zhang, Bang-Le

, p. 1112 - 1120 (2016)

In this work two novel cationic lipids using natural tartaric acid as linking backbone were synthesized. These cationic lipids were simply constructed by tartaric acid backbone using head group 6-aminocaproic acid and saturated hydrocarbon chains dodecanol (T-C12-AH) or hexadecanol (T-C16-AH). The physicochemical properties, gel electrophoresis, transfection activities, and cytotoxicity of cationic liposomes were tested. The optimum formulation for T-C12-AH and T-C16-AH was at cationic lipid/dioleoylphosphatidylethanolamine (DOPE) molar ratio of 1:0.5 and 1:2, respectively, and N/P charge molar ratio of 1:1 and 1:1, respectively. Under optimized conditions, T-C12-AH and T-C16-AH showed effective gene transfection capabilities, superior or comparable to that of commercially available transfecting reagent 3β-[N-(N′,N′-dimethylaminoethyl)carbamoyl]cholesterol (DC-Chol) and N-[2,3-dioleoyloxypropyl]-N,N,N-trimethylammonium chloride (DOTAP). The results demonstrated that the two novel tartaric acid-based cationic lipids exhibited low toxicity and efficient transfection performance, offering an excellent prospect as nonviral vectors for gene delivery.

Development of bioactive gemcitabine-D-Lys6-GnRH prodrugs with linker-controllable drug release rate and enhanced biopharmaceutical profile

Sayyad, Nisar,Vrettos, Eirinaios I.,Karampelas, Theodoros,Chatzigiannis, Christos M.,Spyridaki, Katerina,Liapakis, George,Tamvakopoulos, Constantin,Tzakos, Andreas G.

, p. 256 - 266 (2019)

Peptide-drug conjugates have emerged as a potent approach to enhance the targeting and pharmacokinetic profiles of drugs. However, the impact of the linker unit has not been explored/exploited in depth. Gemcitabine (dFdC) is an anticancer agent used against a variety of solid tumours. Despite its potency, gemcitabine suffers mostly due to its unspecific toxicity, lack of targeting and rapid metabolic inactivation. To minimize these limitations and enable its targeting to tumours overexpressing the GnRH receptor, we examined the peptide-drug conjugation approach. Our design hypothesis was driven by the impact that the linker unit could have on the peptide-drug conjugate efficacy. Along these lines, in order to exploit the potential to manipulate the potency of gemcitabine through altering the linker unit we constructed three different novel peptide-drug conjugates assembled of gemcitabine, the tumour-homing peptide D-Lys6-GnRH and modified linker building blocks. Specifically, the linker was sculpted to either allow slow drug release (utilizing carbamate bond) or rapid disassociation (using amide and ester bonds). Notably, the new analogues possessed up to 95.5-fold enhanced binding affinity for the GnRH receptor (GnRH-R) compared to the natural peptide ligand D-Lys6-GnRH. Additionally, their in vitro cytotoxicity was evaluated in four different cancer cell lines. Their cellular uptake, release of gemcitabine and inactivation of gemcitabine to its inactive metabolite (dFdU) was explored in a representative cell line. In vitro stability and the consequent drug release were evaluated in cell culture medium and human plasma. In vivo pharmacokinetic studies were performed in mice, summarizing the relative stability of the three conjugates and the released levels of gemcitabine in comparison with dFdU. These studies suggest that the fine tuning of the linkage within a peptide-drug conjugate affects the drug release rate and its overall pharmaceutical profile. This could eventually emerge as an intriguing medicinal chemistry approach to optimize bio-profiles of prodrugs.

Remote Amino Acid Recognition Enables Effective Hydrogen Peroxide Activation at a Manganese Oxidation Catalyst

Costas, Miquel,Olivo, Giorgio,Vicens, Laia

supporting information, (2021/12/27)

Precise delivery of a proton plays a key role in O2 activation at iron oxygenases, enabling the crucial O?O cleavage step that generates the oxidizing high-valent metal–oxo species. Such a proton is delivered by acidic residues that may either

Novel bisubstrate uridine-peptide analogues bearing a pyrophosphate bioisostere as inhibitors of human O-GlcNAc transferase

Ryan, Philip,Shi, Yun,von Itzstein, Mark,Rudrawar, Santosh

, (2021/03/06)

Protein O-linked β-D-N-acetylglucosamine (O-GlcNAc) modification (O-GlcNAcylation), an essential post-translational as well as cotranslational modification, is the attachment of β-D-N-acetylglucosamine to serine and threonine residues of nucleocytoplasmic proteins. An aberrant O-GlcNAc profile on certain proteins has been implicated in metabolic diseases such as diabetes and cancer. Inhibitors of O-GlcNAc transferase (OGT) are valuable tools to study the cell biology of protein O-GlcNAc modification. In this study we report novel uridine-peptide conjugate molecules composed of an acceptor peptide covalently linked to a catalytically inactive donor substrate analogue that bears a pyrophosphate bioisostere and explore their inhibitory activities against OGT by a radioactive hOGT assay. Further, we investigate the structural basis of their activities via molecular modelling, explaining their lack of potency towards OGT inhibition.

Thiamine hydrochloride as a recyclable organocatalyst for the efficient and chemoselective N-tert-butyloxycarbonylation of amines

Ingale, Ajit P.,Garad, Dnyaneshwar N.,Ukale, Dattatraya,Thorat, Nitin M.,Shinde, Sandeep V.

supporting information, p. 3791 - 3804 (2021/11/04)

Thiamin hydrochloride promoted highly efficient and ecofriendly approach has been described for the chemoselective N-tert-butyloxycarbonylation of amines under solvent-free conditions at ambient temperature. The demonstrated approach has been applicable for the N-Boc protection of variety of aliphatic, aryl, heteroaryl amines. The chemoselective protection of amino group occurs in chiral amines and amino alcohol without racemization in high yield. Thiamin hydrochloride is stable, economical, easy to handle and environmentally friendly.

TARGET PROTEIN EED DEGRADATION-INDUCING DEGRADUCER, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DISEASES RELATED TO EED, EZH2, OR PRC2, COMPRISING SAME AS ACTIVE INGREDIENT

-

Paragraph 0378-0380, (2021/12/23)

The present invention relates to a target protein degradation-inducing Degraducer, a preparation method thereof, and a pharmaceutical composition for preventing or treating diseases related to EED, EZH2, or PRC2 comprising same as an active ingredient. A novel compound represented by formula 1, according to the present invention is a Degraducer compound that induces degradation of a target protein, i.e., embryonic ectoderm development (EED) or polycomb repressive complex 2 (PRC2), utilizing cereblon E3 ubiquitin ligase, von Hippel-Lindau tumor suppressor (VHL) E3 ubiquitin ligase, mouse double minute 2 homolog (MDM2) E3 ubiquitin ligase, and cellular inhibitor of apoptosis protein 1 (cIAP) E3 ubiquitin ligase, wherein the compound has an aspect of remarkably achieving target protein degradation-inducing activity through a ubiquitin proteasome system (UPS), and therefore there is a useful effect in that it is possible to provide a pharmaceutical composition for preventing or treating diseases or conditions related to a target protein, and a functional health food composition for preventing or improving same, comprising said compound as an active ingredient.

Lipase sensing by naphthalene diimide based fluorescent organic nanoparticles: a solvent induced manifestation of self-assembly

Chakraborty, Debayan,Sarkar, Deblina,Ghosh, Anup Kumar,Das, Prasanta Kumar

, p. 2170 - 2180 (2021/03/14)

The precise control of supramolecular self-assembly is gaining utmost interest for the demanding applications of manifested nano-architecture across the scientific domain. This study delineates the morphological transformation of naphthalene diimide (NDI) derived amphiphiles with varying water content in dimethyl sulfoxide (DMSO) and the selective sensing of lipase using its aggregation-induced emission (AIE) properties. To this end, NDI-based, benzyl alcohol protected alkyl chain (C1, C5, and C10) linked amphiphilic molecules (NDI-1,2,3) were synthesized. Among the synthesized amphiphiles, benzyl ester linked C5 tailored naphthalene diimide (NDI-2) exhibited AIE with an emission maximum at 490 nm in a DMSO-water binary solvent system fromfw= 30% and above water content. The fibrous morphology ofNDI-2atfw= 30% got gradually transformed to spherical aggregated particles along with steady increment in the emission intensity upon increasing the amount of water in DMSO. Atfw= 99% water in DMSO, complete transformation to fluorescent organic nanoparticles (FONPs) was observed. Microscopic and spectroscopic techniques demonstrated the solvent driven morphological transformation and the AIE property ofNDI-2. Moreover, this AIE ofNDI-2FONPs was employed in the selective turn-off sensing of lipase against many other enzymes including esterase, through hydrolysis of a benzyl ester linkage with a limit of detection 10.0 ± 0.8 μg L?1. TheNDI-2FONP also exhibited its lipase sensing efficiencyin vitrousing a human serum sample.

An Integrated Cofactor/Co-Product Recycling Cascade for the Biosynthesis of Nylon Monomers from Cycloalkylamines

Sarak, Sharad,Sung, Sihyong,Jeon, Hyunwoo,Patil, Mahesh D.,Khobragade, Taresh P.,Pagar, Amol D.,Dawson, Philip E.,Yun, Hyungdon

supporting information, p. 3481 - 3486 (2020/12/17)

We report a highly atom-efficient integrated cofactor/co-product recycling cascade employing cycloalkylamines as multifaceted starting materials for the synthesis of nylon building blocks. Reactions using E. coli whole cells as well as purified enzymes produced excellent conversions ranging from >80 and 95 % into desired ω-amino acids, respectively with varying substrate concentrations. The applicability of this tandem biocatalytic cascade was demonstrated to produce the corresponding lactams by employing engineered biocatalysts. For instance, ?-caprolactam, a valuable polymer building block was synthesized with 75 % conversion from 10 mM cyclohexylamine by employing whole-cell biocatalysts. This cascade could be an alternative for bio-based production of ω-amino acids and corresponding lactam compounds.

PROTAC-mediated degradation of class i histone deacetylase enzymes in corepressor complexes

Adams, Grace E.,Cowley, Shaun Michael,Hodgkinson, James T.,Millard, Christopher J.,Norris, James K. S.,Schwabe, John W. R.,Smalley, Joshua P.,Song, Yun

supporting information, p. 4476 - 4479 (2020/05/13)

We have identified a proteolysis targeting chimera (PROTAC) of class I HDACs 1, 2 and 3. The most active degrader consists of a benzamide HDAC inhibitor, an alkyl linker, and the von Hippel-Lindau E3 ligand. Our PROTAC increased histone acetylation levels and compromised colon cancer HCT116 cell viability, establishing a degradation strategy as an alternative to class I HDAC inhibition.

Highly efficient chemoselective N-tert butoxycarbonylation of aliphatic/aromatic/heterocyclic amines using diphenylglycoluril as organocatalyst

Awasthi, Amardeep,Mukherjee, Anagh,Singh, Mandeep,Rathee, Garima,Vanka, Kumar,Chandra, Ramesh

, (2020/05/14)

An efficient approach for the Chemoselective N-tert-butoxycarbonylation of a variety of amines using diphenylglycoluril as organocatalyst has been described. For the first time, a plausible mechanism for the N-tert-butoxycarbonylation has been proposed using density functional theory (DFT) calculations supported by NMR studies. The reusability of the organocatalyst and observation of the desired N-Boc protected amines being formed without the formation of side products like urea, oxazolidinone, isocyanate, and N, N-di-Boc derivatives makes the present protocol desirable.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 6404-29-1